Ageing as a Risk Factor for Disease

Age is the main risk factor for the prevalent diseases of developed countries: cancer, cardiovascular disease and neurodegeneration. The ageing process is deleterious for fitness, but can nonetheless evolve as a consequence of the declining force of natural selection at later ages, attributable to extrinsic hazards to survival: ageing can then occur as a side-effect of accumulation of mutations that lower fitness at later ages, or of natural selection in favour of mutations that increase fitness of the young but at the cost of a higher subsequent rate of ageing. Once thought of as an inexorable, complex and lineage-specific process of accumulation of damage, ageing has turned out to be influenced by mechanisms that show strong evolutionary conservation. Lowered activity of the nutrient-sensing insulin/insulin-like growth factor/Target of Rapamycin signalling network can extend healthy lifespan in yeast, multicellular invertebrates, mice and, possibly, humans. Mitochondrial activity can also promote ageing, while genome maintenance and autophagy can protect against it. We discuss the relationship between evolutionarily conserved mechanisms of ageing and disease, and the associated scientific challenges and opportunities.

[1]  Stuart K. Kim,et al.  Genetics and genomics of human ageing , 2011, Philosophical Transactions of the Royal Society B: Biological Sciences.

[2]  T. Hunter,et al.  Oncogenic kinase signalling , 2001, Nature.

[3]  M. Klass A method for the isolation of longevity mutants in the nematode Caenorhabditis elegans and initial results , 1983, Mechanisms of Ageing and Development.

[4]  C. Kenyon,et al.  A C. elegans mutant that lives twice as long as wild type , 1993, Nature.

[5]  Emma Saavedra,et al.  The causes of cancer revisited: "mitochondrial malignancy" and ROS-induced oncogenic transformation - why mitochondria are targets for cancer therapy. , 2010, Molecular aspects of medicine.

[6]  D. Gems,et al.  Increased life span from overexpression of superoxide dismutase in Caenorhabditis elegans is not caused by decreased oxidative damage , 2011, Free radical biology & medicine.

[7]  R. Kurzrock,et al.  Autophagy as a target for anticancer therapy , 2011, Nature Reviews Clinical Oncology.

[8]  N. LeBrasseur,et al.  Clearance of p16Ink4a-positive senescent cells delays ageing-associated disorders , 2011, Nature.

[9]  Young-Jae Nam,et al.  The Mitochondrial Death Pathway and Cardiac Myocyte Apoptosis , 2004, Circulation research.

[10]  M. Beal,et al.  Autophagy in neurodegenerative disorders: pathogenic roles and therapeutic implications , 2010, Trends in Neurosciences.

[11]  Manuel Serrano,et al.  The common biology of cancer and ageing , 2007, Nature.

[12]  J. Hayashi,et al.  ROS-Generating Mitochondrial DNA Mutations Can Regulate Tumor Cell Metastasis , 2008, Science.

[13]  P. Salvaterra,et al.  Brain aging and Aβ1–42 neurotoxicity converge via deterioration in autophagy–lysosomal system: a conditional Drosophila model linking Alzheimer’s neurodegeneration with aging , 2011, Acta Neuropathologica.

[14]  L. Partridge The new biology of ageing , 2010, Philosophical Transactions of the Royal Society B: Biological Sciences.

[15]  B. Yankner,et al.  Neural mechanisms of ageing and cognitive decline , 2010, Nature.

[16]  T. Jacks,et al.  Restoration of p53 function leads to tumour regression in vivo , 2007, Nature.

[17]  L. Fontana,et al.  Calorie restriction and prevention of age‐associated chronic disease , 2011, FEBS letters.

[18]  A. Trifunovic,et al.  Mitochondrial energy metabolism and ageing. , 2010, Biochimica et biophysica acta.

[19]  Vicente Andrés,et al.  Telomere Biology and Cardiovascular Disease , 2006, Circulation research.

[20]  B. Zhivotovsky,et al.  Mitochondria in cancer cells: what is so special about them? , 2008, Trends in cell biology.

[21]  T. Johnson,et al.  Increased life-span of age-1 mutants in Caenorhabditis elegans and lower Gompertz rate of aging. , 1990, Science.

[22]  A. Kimmelman,et al.  The dynamic nature of autophagy in cancer. , 2011, Genes & development.

[23]  T. Montine,et al.  Intranasal Insulin Therapy for Alzheimer Disease and Amnestic Mild Cognitive Impairment A Pilot Clinical Trial , 2011 .

[24]  U. Brunk,et al.  The mitochondrial-lysosomal axis theory of aging: accumulation of damaged mitochondria as a result of imperfect autophagocytosis. , 2002, European journal of biochemistry.

[25]  C M McCay,et al.  The effect of retarded growth upon the length of life span and upon the ultimate body size. 1935. , 1935, Nutrition.

[26]  F. Gao,et al.  Insulin says NO to cardiovascular disease. , 2011, Cardiovascular research.

[27]  L. Partridge,et al.  Dietary restriction delays aging, but not neuronal dysfunction, in Drosophila models of Alzheimer's disease , 2011, Neurobiology of Aging.

[28]  Richard A. Miller,et al.  Rebuttal to Hasty and Vijg: ‘Accelerating aging by mouse reverse genetics: a rational approach to understanding longevity’ , 2004, Aging cell.

[29]  S. Pletcher,et al.  Realized immune response is enhanced in long-lived puc and chico mutants but is unaffected by dietary restriction. , 2008, Molecular immunology.

[30]  S. Verma,et al.  DNA damage repair and cardiovascular diseases. , 2010, The Canadian journal of cardiology.

[31]  J. Hoeijmakers,et al.  Age to survive: DNA damage and aging. , 2008, Trends in genetics : TIG.

[32]  S. Oldham Obesity and nutrient sensing TOR pathway in flies and vertebrates: Functional conservation of genetic mechanisms , 2011, Trends in Endocrinology & Metabolism.

[33]  L. Partridge,et al.  Mechanisms of Life Span Extension by Rapamycin in the Fruit Fly Drosophila melanogaster , 2010, Cell metabolism.

[34]  R. Tian,et al.  Targeting AMPK for cardiac protection: opportunities and challenges. , 2011, Journal of molecular and cellular cardiology.

[35]  D. Peeper,et al.  Oncogene-induced cell senescence--halting on the road to cancer. , 2006, The New England journal of medicine.

[36]  K. Moore,et al.  Macrophages in the Pathogenesis of Atherosclerosis , 2011, Cell.

[37]  A. Bokov,et al.  Is the oxidative stress theory of aging dead? , 2009, Biochimica et biophysica acta.

[38]  W. Wurst,et al.  Telomere shortening reduces Alzheimer's disease amyloid pathology in mice. , 2011, Brain : a journal of neurology.

[39]  Shan Jiang,et al.  Telomerase reactivation reverses tissue degeneration in aged telomerase deficient mice , 2010, Nature.

[40]  M. Mattson,et al.  Anti-apoptotic Role of Telomerase in Pheochromocytoma Cells* , 1999, The Journal of Biological Chemistry.

[41]  D. Garigan,et al.  Mutations That Increase the Life Span of C. elegans Inhibit Tumor Growth , 2006, Science.

[42]  C. Kenyon The genetics of ageing , 2010, Nature.

[43]  N. Fujii,et al.  Glucose Metabolism and Energy Homeostasis in Mouse Hearts Overexpressing Dominant Negative α2 Subunit of AMP-activated Protein Kinase* , 2003, Journal of Biological Chemistry.

[44]  Frederick W. Alt,et al.  DNA Repair, Genome Stability, and Aging , 2005, Cell.

[45]  B B Yodh,et al.  Unsolved Problem , 1997 .

[46]  Nektarios Tavernarakis,et al.  Can autophagy promote longevity? , 2010, Nature Cell Biology.

[47]  L. E. Donate,et al.  Telomeres in cancer and ageing , 2011, Philosophical Transactions of the Royal Society B: Biological Sciences.

[48]  M. Mattson,et al.  Mitochondrial DNA damage and repair in neurodegenerative disorders. , 2008, DNA repair.

[49]  D. Rubinsztein,et al.  Autophagy and Aging , 2011, Cell.

[50]  George C. Williams,et al.  PLEIOTROPY, NATURAL SELECTION, AND THE EVOLUTION OF SENESCENCE , 1957, Science of Aging Knowledge Environment.

[51]  C. Kahn,et al.  A Kinase-Independent Role for Unoccupied Insulin and IGF-1 Receptors in the Control of Apoptosis , 2010, Science Signaling.

[52]  W. Hamilton The moulding of senescence by natural selection. , 1966, Journal of theoretical biology.

[53]  Jan Vijg,et al.  Accelerating aging by mouse reverse genetics: a rational approach to understanding longevity , 2004, Aging cell.

[54]  R. Shaw,et al.  The AMPK signalling pathway coordinates cell growth, autophagy and metabolism , 2011, Nature Cell Biology.

[55]  L. Partridge,et al.  Measurement of H2O2 within Living Drosophila during Aging Using a Ratiometric Mass Spectrometry Probe Targeted to the Mitochondrial Matrix , 2011, Cell metabolism.

[56]  R. Hajjar,et al.  AKT signalling in the failing heart , 2011, European journal of heart failure.

[57]  D. Rubinsztein,et al.  Regulation of mammalian autophagy in physiology and pathophysiology. , 2010, Physiological reviews.

[58]  Sang-Kyu Park Genomic approaches for the understanding of aging in model organisms. , 2011, BMB reports.

[59]  I. Torres-Aleman,et al.  The many faces of insulin-like peptide signalling in the brain , 2012, Nature Reviews Neuroscience.

[60]  M. Pagel,et al.  Comparative biology of mammalian telomeres: hypotheses on ancestral states and the roles of telomeres in longevity determination , 2011, Aging cell.

[61]  David Gems,et al.  Against the oxidative damage theory of aging: superoxide dismutases protect against oxidative stress but have little or no effect on life span in Caenorhabditis elegans. , 2008, Genes & development.

[62]  X. Pi-Sunyer,et al.  Metformin effects revisited. , 2012, Diabetes research and clinical practice.

[63]  Carlos Cordon-Cardo,et al.  Senescence and tumour clearance is triggered by p53 restoration in murine liver carcinomas , 2007, Nature.

[64]  Kira Glover-Cutter,et al.  TOR signaling and rapamycin influence longevity by regulating SKN-1/Nrf and DAF-16/FoxO. , 2012, Cell metabolism.

[65]  L. Galluzzi,et al.  Targeting mitochondria for cancer therapy , 2010, Nature Reviews Drug Discovery.

[66]  Linda Partridge,et al.  Extending Healthy Life Span—From Yeast to Humans , 2010, Science.

[67]  A. Padovani,et al.  The role of mitochondria in neurodegenerative diseases , 2011, Journal of Neurology.

[68]  Dimitris Kletsas,et al.  Activation of the DNA damage checkpoint and genomic instability in human precancerous lesions , 2005, Nature.

[69]  Marta Martínez-Vicente,et al.  Fighting neurodegeneration with rapamycin: mechanistic insights , 2011, Nature Reviews Neuroscience.

[70]  A. McKee,et al.  Modulation of lipid peroxidation and mitochondrial function improves neuropathology in Huntington’s disease mice , 2011, Acta Neuropathologica.

[71]  Jianhua Zhang,et al.  Autophagy, mitochondria and oxidative stress: cross-talk and redox signalling , 2011, The Biochemical journal.

[72]  L. Partridge,et al.  Insulin/IGF-like signalling, the central nervous system and aging. , 2009, The Biochemical journal.

[73]  M. Beekman,et al.  Genomics of human longevity , 2011, Philosophical Transactions of the Royal Society B: Biological Sciences.

[74]  P. Distefano,et al.  Ageing and metabolism: drug discovery opportunities , 2005, Nature Reviews Drug Discovery.

[75]  Tao Wang,et al.  TOR-mediated autophagy regulates cell death in Drosophila neurodegenerative disease , 2009, The Journal of cell biology.

[76]  I. Kohane,et al.  Gene regulation and DNA damage in the ageing human brain , 2004, Nature.

[77]  T. Kirkwood Understanding ageing from an evolutionary perspective , 2008, Journal of internal medicine.

[78]  Hiroyuki Tsutsui,et al.  [Oxidative stress and heart failure]. , 2006, Nihon rinsho. Japanese journal of clinical medicine.

[79]  V. Fuster,et al.  Cellular Senescence, Vascular Disease, and Aging: Part 1 of a 2-Part Review , 2011, Circulation.

[80]  T. P. Neufeld,et al.  Atg7-dependent autophagy promotes neuronal health, stress tolerance, and longevity but is dispensable for metamorphosis in Drosophila. , 2007, Genes & development.

[81]  Howard T. Jacobs,et al.  Premature ageing in mice expressing defective mitochondrial DNA polymerase , 2004, Nature.

[82]  B. Zlokovic Neurovascular pathways to neurodegeneration in Alzheimer's disease and other disorders , 2011, Nature Reviews Neuroscience.

[83]  R. Bloomer,et al.  Impact of caloric and dietary restriction regimens on markers of health and longevity in humans and animals: a summary of available findings , 2011, Nutrition journal.

[84]  Jason K. Kim,et al.  New insights into insulin resistance in the diabetic heart , 2011, Trends in Endocrinology & Metabolism.

[85]  A. Ashworth,et al.  The DNA damage response and cancer therapy , 2012, Nature.

[86]  Yuling Hong,et al.  Ideal Cardiovascular Health and Mortality From All Causes and Diseases of the Circulatory System Among Adults in the United States , 2012, Circulation.

[87]  D. Lawlor,et al.  Hyperinsulinaemia and Increased Risk of Breast Cancer: Findings From the British Women's Heart and Health Study , 2004, Cancer Causes & Control.

[88]  H. Bernstein,et al.  DNA repair/pro-apoptotic dual-role proteins in five major DNA repair pathways: fail-safe protection against carcinogenesis. , 2002, Mutation research.

[89]  M. Driscoll,et al.  Metformin Induces a Dietary Restriction–Like State and the Oxidative Stress Response to Extend C. elegans Healthspan via AMPK, LKB1, and SKN-1 , 2010, PloS one.

[90]  V. Bohr,et al.  DNA repair, mitochondria, and neurodegeneration , 2007, Neuroscience.

[91]  Zhaohui Feng,et al.  The Regulation of Aging and Longevity: A New and Complex Role of p53. , 2011, Genes & cancer.

[92]  K. Ocorr,et al.  High-fat-diet-induced obesity and heart dysfunction are regulated by the TOR pathway in Drosophila. , 2010, Cell metabolism.

[93]  Christian Gieger,et al.  Genetic variation near IRS1 associates with reduced adiposity and an impaired metabolic profile , 2011, Nature Genetics.

[94]  L. Partridge,et al.  A longer and healthier life with TOR down-regulation: genetics and drugs. , 2011, Biochemical Society transactions.

[95]  D. Withers,et al.  Mammalian models of extended healthy lifespan , 2011, Philosophical Transactions of the Royal Society B: Biological Sciences.

[96]  H A Kestler,et al.  Chitinase enzyme activity in CSF is a powerful biomarker of Alzheimer disease , 2012, Neurology.

[97]  S. Przedborski,et al.  PINK1/Parkin direct mitochondria to autophagy , 2010, Autophagy.

[98]  Ming-Rong Wang,et al.  Mammalian target of rapamycin up-regulation of pyruvate kinase isoenzyme type M2 is critical for aerobic glycolysis and tumor growth , 2011, Proceedings of the National Academy of Sciences.

[99]  V. Anisimov Metformin for aging and cancer prevention , 2010, Aging.

[100]  Z. Tümer,et al.  Subtelomeric study of 132 patients with mental retardation reveals 9 chromosomal anomalies and contributes to the delineation of submicroscopic deletions of 1pter, 2qter, 4pter, 5qter and 9qter , 2005, BMC Medical Genetics.

[101]  A. Barzilai DNA damage, neuronal and glial cell death and neurodegeneration , 2010, Apoptosis.

[102]  M. Birnbaum,et al.  AMP-activated protein kinase mediates ischemic glucose uptake and prevents postischemic cardiac dysfunction, apoptosis, and injury. , 2004, The Journal of clinical investigation.

[103]  J. Franklin,et al.  The Mitochondria-Targeted Antioxidant MitoQ Prevents Loss of Spatial Memory Retention and Early Neuropathology in a Transgenic Mouse Model of Alzheimer's Disease , 2011, The Journal of Neuroscience.

[104]  J. Haldane New paths in genetics , 1942 .

[105]  S. Craft,et al.  Insulin resistance and pathological brain ageing , 2011, Diabetic medicine : a journal of the British Diabetic Association.

[106]  Mayuko Nishimura,et al.  Drosophila as a model to study cardiac aging , 2011, Experimental Gerontology.

[107]  M. Blagosklonny TOR-driven aging: Speeding car without brakes , 2009, Cell cycle.

[108]  T. Ørntoft,et al.  DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis , 2005, Nature.

[109]  Jayanta Debnath,et al.  Inhibition of mTOR by Rapamycin Abolishes Cognitive Deficits and Reduces Amyloid-β Levels in a Mouse Model of Alzheimer's Disease , 2010, PloS one.

[110]  P. Medawar UNSOLVED problem of biology. , 1953, The Medical journal of Australia.

[111]  E. Leventhal,et al.  Aging, immunity, and cancer. , 2000, Cancer control : journal of the Moffitt Cancer Center.

[112]  P. Dupont,et al.  Increased energy metabolism rescues glia-induced pathology in a Drosophila model of Huntington's disease. , 2010, Human molecular genetics.

[113]  J. DeGregori,et al.  Challenging the axiom: does the occurrence of oncogenic mutations truly limit cancer development with age? , 2013, Oncogene.

[114]  L. Cantley,et al.  Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation , 2009, Science.

[115]  A. Boyle,et al.  The aging heart and post-infarction left ventricular remodeling. , 2011, Journal of the American College of Cardiology.

[116]  M. Eccles,et al.  No evidence of substantia nigra telomere shortening in Parkinson's disease , 2011, Neurobiology of Aging.

[117]  P. Klatt,et al.  Delayed ageing through damage protection by the Arf/p53 pathway , 2007, Nature.

[118]  M. Pallàs,et al.  Role of Cell Cycle Re-Entry in Neurons: A Common Apoptotic Mechanism of Neuronal Cell Death , 2011, Neurotoxicity Research.

[119]  K. Bornfeldt,et al.  Insulin resistance, hyperglycemia, and atherosclerosis. , 2011, Cell metabolism.

[120]  L. Kirshenbaum,et al.  Autophagy in the Heart: Too Much of a Good Thing? , 2012, Journal of cardiovascular pharmacology.

[121]  Z. D. Sharp,et al.  Aging and cancer: can mTOR inhibitors kill two birds with one drug? , 2011, Targeted Oncology.

[122]  B. Lu,et al.  Mitochondrial dynamics and mitophagy in Parkinson's disease: disordered cellular power plant becomes a big deal in a major movement disorder , 2011, Current Opinion in Neurobiology.

[123]  D. Malkin,et al.  Hereditary cancer predisposition in children: Genetic basis and clinical implications , 2006, International journal of cancer.

[124]  L. Partridge,et al.  Death and dessert: nutrient signalling pathways and ageing. , 2011, Current opinion in cell biology.